One indirect approach to identify POLE-mutated cancers is by looking at the number of tumor-infiltrating lymphocytes (TILs), as we know that a highly mutated microenvironment expresses more antigens and, therefore, activates the host’s immune system. The gene discussed is POLE; the disease is neoplasm.